These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31774334)

  • 1. Minority
    Engelthaler DM; Streicher EM; Kelley EJ; Allender CJ; Wiggins K; Jimenez D; Lemmer D; Vittinghoff E; Theron G; Sirgel FA; Warren RM; Metcalfe JZ
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):789-791. PubMed ID: 31774334
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.
    Zhang D; Gomez JE; Chien JY; Haseley N; Desjardins CA; Earl AM; Hsueh PR; Hung DT
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6600-6608. PubMed ID: 27572408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise selection of mutation conferring fluroquinolone resistance: multisite MDR-TB cohort study.
    Gao J; Du J; Shu W; Liu Y; Wang Y; Xue Z; Li L; Pang Y
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1767-1771. PubMed ID: 33604720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.
    Metcalfe JZ; Streicher E; Theron G; Colman RE; Penaloza R; Allender C; Lemmer D; Warren RM; Engelthaler DM
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    Chang KC; Yew WW; Chan RC
    J Antimicrob Chemother; 2010 Aug; 65(8):1551-61. PubMed ID: 20542907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
    Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
    Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some Synonymous and Nonsynonymous
    Ajileye A; Alvarez N; Merker M; Walker TM; Akter S; Brown K; Moradigaravand D; Schön T; Andres S; Schleusener V; Omar SV; Coll F; Huang H; Diel R; Ismail N; Parkhill J; de Jong BC; Peto TE; Crook DW; Niemann S; Robledo J; Smith EG; Peacock SJ; Köser CU
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
    Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
    J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.
    Martinez E; Hennessy D; Jelfs P; Crighton T; Chen SC; Sintchenko V
    Tuberculosis (Edinb); 2018 Jul; 111():31-34. PubMed ID: 30029911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to first-line drugs and major genotypic lineages of Mycobacterium tuberculosis in the 3 French Department of the Americas: Profiles, evolution, and trends (1995-2011)].
    Millet J; Berchel M; Prudenté F; Streit E; Bomer AG; Schuster F; Vanhomwegen J; Paasch D; Galbert I; Valery E; Aga R; Rastogi N
    Bull Soc Pathol Exot; 2014 May; 107(2):90-105. PubMed ID: 24627041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria.
    Bouziane F; Allem R; Sebaihia M; Kumanski S; Mougari F; Sougakoff W; Raskine L; Yala D; Cambau E;
    J Glob Antimicrob Resist; 2019 Dec; 19():301-307. PubMed ID: 31100498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].
    Mindru R; Spînu V; Popa C; Botezatu E; Spătaru R
    Pneumologia; 2014; 63(3):168-73. PubMed ID: 25420292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture.
    O'Sullivan DM; McHugh TD; Gillespie SH
    J Med Microbiol; 2010 Dec; 59(Pt 12):1533-1535. PubMed ID: 20724506
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
    Pérez-García F; Ruiz-Serrano MJ; López Roa P; Acosta F; Pérez-Lago L; García-De-Viedma D; Bouza E
    J Microbiol Methods; 2017 Aug; 139():74-78. PubMed ID: 28511895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
    de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.